Medication info
Lipitor 80 mg (Atorvastatin Calcium Trihydrate)

Lipitor 80 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›86.8mg / 1 tablet
Manufacturer / importer
Viatris
Appearance
White round film-coated tablet
Packaging
28 tablets/PTP [(7 tablets/PTP packaging * 4)]
Approval status
Active

MFDS item code 200711422 · Approved 2007.10.18 · Insurance code 073400380

Summary

Main use
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45% or more is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking treatment goals and response into consideration. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.

Ingredients

Importer
Viatris

Efficacy & effects

Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
View approved original text

This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease, and also reduces the risk of vascular interventions and chronic stable angina. It is effective in reducing the risk of myocardial infarction and stroke in patients with type 2 diabetes. For patients with coronary heart disease, it helps reduce the risk of nonfatal myocardial infarction, fatal and nonfatal strokes, vascular interventions, heart failure hospitalization, and angina. Additionally, in patients with hyperlipidemia, it lowers total cholesterol and bad cholesterol (LDL), apolipoprotein B, and triglyceride levels, while increasing good cholesterol (HDL) levels. It is useful for patients with primary and mixed dyslipidemia, dysbetalipoproteinemia, and familial hypercholesterolemia. This medication is effective in improving cardiovascular health and treating hyperlipidemia.

How to take

Adult dose

Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45% or more is required). This drug is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking treatment goals and response into consideration. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are similar to those in the general adult patient population.

Precautions

This medication may cause muscle-related symptoms, so if severe muscle pain or weakness is felt, it should be discontinued immediately and a doctor consulted. This medication can affect liver function, so it should not be taken if there is liver disease or elevated liver enzymes, and regular liver function tests should be performed while taking it. Pregnant women or those who may become pregnant should not take this medication and must use appropriate contraception during treatment. Breastfeeding women should also refrain from taking this medication and may need to consider stopping breastfeeding or exploring alternative treatments. This medication can cause severe allergic reactions, such as specific allergic responses or skin rashes; if such symptoms occur, it should be discontinued immediately and medical personnel informed. Elderly patients or those with impaired kidney function are at higher risk for muscle-related side effects, so caution is required during use, and regular monitoring is recommended. There is a possibility of interactions with other medications, especially those affecting liver metabolism, certain antibiotics, antifungal agents, and antiviral drugs, so consultation with a doctor or pharmacist is essential when taking them together. Grapefruit juice may increase the blood concentration of this medication, so it is advisable to avoid grapefruit juice. If symptoms such as muscle pain, weakness, fever, or fatigue appear during treatment, a doctor should be notified immediately for appropriate testing. Children and pediatric patients under 10 years of age should not take this medication, and long-term safety in children under 18 has not been fully established. There are no specific antidotes for overdose, so appropriate treatment should be administered based on symptoms, and liver function and muscle-related parameters should be monitored. This medication should be kept out of reach of children and stored in its original container to prevent misuse or degradation of quality.

Side effects

  • Apathy
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 169 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngeal and laryngeal pain
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • hepatic failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • allergic angioedema
  • erythema multiforme
  • stomatitis
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocyte
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • elevated potassium
  • increased BUN
  • cerebrovascular accident
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormalities in liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia
  • contractures
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • breast fibrocystic changes
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • increased appetite
  • vasomotor edema
  • chest pain
  • angina
  • facial edema
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • changes in the cornea
  • altered taste
  • cerebral hemorrhage
  • optic nerve atrophy
  • episodic tonic-clonic seizures
  • central nervous system vascular injury

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and the storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Storing it this way will help preserve its effectiveness.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

28 tablets/PTP [(7 tablets/PTP packaging * 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.